178 related articles for article (PubMed ID: 16784838)
1. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease.
Lambrechts D; Carmeliet P
Biochim Biophys Acta; 2006; 1762(11-12):1109-21. PubMed ID: 16784838
[TBL] [Abstract][Full Text] [Related]
2. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
3. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
[TBL] [Abstract][Full Text] [Related]
4. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection.
Storkebaum E; Lambrechts D; Carmeliet P
Bioessays; 2004 Sep; 26(9):943-54. PubMed ID: 15351965
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.
Alisky JM; Davidson BL
Hum Gene Ther; 2000 Nov; 11(17):2315-29. PubMed ID: 11096437
[TBL] [Abstract][Full Text] [Related]
6. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?
Lambrechts D; Storkebaum E; Carmeliet P
Trends Mol Med; 2004 Jun; 10(6):275-82. PubMed ID: 15177192
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular Delivery in Mice for Motor Neuron Diseases.
Nizzardo M; Rizzuti M
Methods Mol Biol; 2017; 1565():229-239. PubMed ID: 28364247
[TBL] [Abstract][Full Text] [Related]
9. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.
Storkebaum E; Lambrechts D; Dewerchin M; Moreno-Murciano MP; Appelmans S; Oh H; Van Damme P; Rutten B; Man WY; De Mol M; Wyns S; Manka D; Vermeulen K; Van Den Bosch L; Mertens N; Schmitz C; Robberecht W; Conway EM; Collen D; Moons L; Carmeliet P
Nat Neurosci; 2005 Jan; 8(1):85-92. PubMed ID: 15568021
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype.
Lambrechts D; Poesen K; Fernández-Santiago R; Al-Chalabi A; Del Bo R; Van Vught PW; Khan S; Marklund SL; Brockington A; van Marion I; Anneser J; Shaw C; Ludolph AC; Leigh NP; Comi GP; Gasser T; Shaw PJ; Morrison KE; Andersen PM; Van den Berg LH; Thijs V; Siddique T; Robberecht W; Carmeliet P
J Med Genet; 2009 Dec; 46(12):840-6. PubMed ID: 18413368
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
[TBL] [Abstract][Full Text] [Related]
13. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.
Van Den Bosch L; Storkebaum E; Vleminckx V; Moons L; Vanopdenbosch L; Scheveneels W; Carmeliet P; Robberecht W
Neurobiol Dis; 2004 Oct; 17(1):21-8. PubMed ID: 15350962
[TBL] [Abstract][Full Text] [Related]
14. Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
Winner B; Marchetto MC; Winkler J; Gage FH
Hum Mol Genet; 2014 Sep; 23(R1):R27-34. PubMed ID: 24821704
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
Bogaert E; Van Damme P; Van Den Bosch L; Robberecht W
Muscle Nerve; 2006 Oct; 34(4):391-405. PubMed ID: 16856151
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
O'Connor DM; Boulis NM
Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
[TBL] [Abstract][Full Text] [Related]
17. AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.
Dodge JC; Treleaven CM; Fidler JA; Hester M; Haidet A; Handy C; Rao M; Eagle A; Matthews JC; Taksir TV; Cheng SH; Shihabuddin LS; Kaspar BK
Mol Ther; 2010 Dec; 18(12):2075-84. PubMed ID: 20859261
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis.
Brockington A; Wharton SB; Fernando M; Gelsthorpe CH; Baxter L; Ince PG; Lewis CE; Shaw PJ
J Neuropathol Exp Neurol; 2006 Jan; 65(1):26-36. PubMed ID: 16410746
[TBL] [Abstract][Full Text] [Related]
19. Another angiogenic gene linked to amyotrophic lateral sclerosis.
Lambrechts D; Lafuste P; Carmeliet P; Conway EM
Trends Mol Med; 2006 Aug; 12(8):345-7. PubMed ID: 16843725
[TBL] [Abstract][Full Text] [Related]
20. Cellular therapies in motor neuron diseases.
Nayak MS; Kim YS; Goldman M; Keirstead HS; Kerr DA
Biochim Biophys Acta; 2006; 1762(11-12):1128-38. PubMed ID: 16872810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
